Literature DB >> 33617650

Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease.

Jodie B Nichols1, Michael Malek-Ahmadi2, Pierre N Tariot2, Geidy E Serrano3, Lucia I Sue3, Thomas G Beach3.   

Abstract

We sought to determine the associations among cerebral amyloid angiopathy (CAA), white matter rarefaction (WMR), circle of Willis atherosclerosis (CWA), and total microinfarct number with Braak neurofibrillary stage in postmortem individuals with and without Alzheimer disease (AD). Data from 355 cases of autopsied individuals with Braak stage I-VI who had antemortem consensus diagnoses of cognitively unimpaired (n = 183), amnestic mild cognitive impairment (n = 31), and AD dementia (n = 141) were used. The association between Braak stage and vascular lesions were individually assessed using multivariable linear regression that adjusted for age at death, APOE ε4 carrier status, sex, education, and neuritic plaque density. CAA (p = 0.007) and WMR (p < 0.001) were associated with Braak stage, independent of amyloid load; microinfarct number and CWA showed no association. Analyses of the interactions between APOE ε4 carrier status and vascular lesions found that greater WMR and positive ε4 carrier status were associated with higher Braak stages. These results suggest that CAA and WMR are statistically linked to the severity of AD-related NFT pathology. The statistical link between WMR and NFT load may be strengthened by the presence of APOE ε4 carrier status. An additional finding was that Lewy body pathology was most prevalent in higher Braak stages.
© 2021 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Braak stage; Cerebral amyloid angiopathy; Mild cognitive impairment; Neurofibrillary tangles; White matter rarefaction

Mesh:

Substances:

Year:  2021        PMID: 33617650      PMCID: PMC7899190          DOI: 10.1093/jnen/nlaa160

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  59 in total

1.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Authors:  Bradley T Hyman; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Maria C Carrillo; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; Bill Thies; John Q Trojanowski; Harry V Vinters; Thomas J Montine
Journal:  Alzheimers Dement       Date:  2012-01       Impact factor: 21.566

2.  Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles.

Authors:  Thomas G Beach; Jeffrey R Wilson; Lucia I Sue; Amanda Newell; Marissa Poston; Raquel Cisneros; Yoga Pandya; Chera Esh; Donald J Connor; Marwan Sabbagh; Douglas G Walker; Alex E Roher
Journal:  Acta Neuropathol       Date:  2006-09-20       Impact factor: 17.088

3.  Microinfarct pathology, dementia, and cognitive systems.

Authors:  Zoe Arvanitakis; Sue E Leurgans; Lisa L Barnes; David A Bennett; Julie A Schneider
Journal:  Stroke       Date:  2011-01-06       Impact factor: 7.914

4.  Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Geidy Serrano; Holly A Shill; Douglas G Walker; LihFen Lue; Alex E Roher; Brittany N Dugger; Chera Maarouf; Alex C Birdsill; Anthony Intorcia; Megan Saxon-Labelle; Joel Pullen; Alexander Scroggins; Jessica Filon; Sarah Scott; Brittany Hoffman; Angelica Garcia; John N Caviness; Joseph G Hentz; Erika Driver-Dunckley; Sandra A Jacobson; Kathryn J Davis; Christine M Belden; Kathy E Long; Michael Malek-Ahmadi; Jessica J Powell; Lisa D Gale; Lisa R Nicholson; Richard J Caselli; Bryan K Woodruff; Steven Z Rapscak; Geoffrey L Ahern; Jiong Shi; Anna D Burke; Eric M Reiman; Marwan N Sabbagh
Journal:  Neuropathology       Date:  2015-01-26       Impact factor: 1.906

5.  -1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein.

Authors:  Mohamed Ali Smach; Bassem Charfeddine; Leila Ben Othman; Turkia Lammouchi; Afef Ltaief; Souhir Nafati; Hedi Dridi; Soufien Bennamou; Khalifa Limem
Journal:  Neurosci Lett       Date:  2010-02-04       Impact factor: 3.046

6.  Frontal lobe degeneration of non-Alzheimer type. IV. White matter changes.

Authors:  E Englund; A Brun
Journal:  Arch Gerontol Geriatr       Date:  1987-09       Impact factor: 3.250

Review 7.  Pathological Changes of Tau Related to Alzheimer's Disease.

Authors:  Dandan Chu; Fei Liu
Journal:  ACS Chem Neurosci       Date:  2018-10-23       Impact factor: 4.418

Review 8.  Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders.

Authors:  Robert W Mahley
Journal:  J Mol Med (Berl)       Date:  2016-06-09       Impact factor: 4.599

9.  Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.

Authors:  Isabelle Bos; Frans R Verhey; Inez H G B Ramakers; Heidi I L Jacobs; Hilkka Soininen; Yvonne Freund-Levi; Harald Hampel; Magda Tsolaki; Åsa K Wallin; Mark A van Buchem; Ania Oleksik; Marcel M Verbeek; Marcel Olde Rikkert; Wiesje M van der Flier; Philip Scheltens; Pauline Aalten; Pieter Jelle Visser; Stephanie J B Vos
Journal:  Alzheimers Res Ther       Date:  2017-12-29       Impact factor: 6.982

10.  Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition.

Authors:  Jessica R Filon; Anthony J Intorcia; Lucia I Sue; Elsa Vazquez Arreola; Jeffrey Wilson; Kathryn J Davis; Marwan N Sabbagh; Christine M Belden; Richard J Caselli; Charles H Adler; Bryan K Woodruff; Steven Z Rapscak; Geoffrey L Ahern; Anna D Burke; Sandra Jacobson; Holly A Shill; Erika Driver-Dunckley; Kewei Chen; Eric M Reiman; Thomas G Beach; Geidy E Serrano
Journal:  J Neuropathol Exp Neurol       Date:  2016-06-12       Impact factor: 3.685

View more
  4 in total

1.  Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-04-29       Impact factor: 3.575

2.  Discovering Gene Signature Shared by Prostate Cancer and Neurodegenerative Diseases Based on the Bioinformatics Approach.

Authors:  Qiang Su; Bin Dai; Hanjian Zhang; Shengqiang Zhang
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

3.  Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer's Disease in Humans.

Authors:  Christopher E Ramsden; Gregory S Keyes; Elizabeth Calzada; Mark S Horowitz; Daisy Zamora; Jahandar Jahanipour; Andrea Sedlock; Fred E Indig; Ruin Moaddel; Dimitrios Kapogiannis; Dragan Maric
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

4.  Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia.

Authors:  Diego Sepulveda-Falla; Justin S Sanchez; Kenneth S Kosik; Francisco Lopera; Yakeel T Quiroz; Maria Camila Almeida; Daniela Boassa; Juliana Acosta-Uribe; Clara Vila-Castelar; Liliana Ramirez-Gomez; Ana Baena; David Aguillon; Nelson David Villalba-Moreno; Jessica Lisa Littau; Andres Villegas; Thomas G Beach; Charles L White; Mark Ellisman; Susanne Krasemann; Markus Glatzel; Keith A Johnson; Reisa A Sperling; Eric M Reiman; Joseph F Arboleda-Velasquez
Journal:  Acta Neuropathol       Date:  2022-07-15       Impact factor: 15.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.